In ₹ Crore except Per Share Latest Annual	FORTIS FY26	APOLLOHOSP FY26	MAXHEALTH FY26	MEDANTA FY26	Peer Average
Valuation — at last close
P/E	◆ 54.70×	60.72×	57.39×	62.76×	60.29× -9%
P/B	◆ 5.76×	12.44×	7.71×	8.82×	9.65× -40%
EV/EBITDA	◆ 28.57×	32.35×	38.17×	38.09×	36.20× -21%
Market Cap	₹56,992 Cr	₹1.18L Cr	₹82,828 Cr	₹34,922 Cr	₹78,555 Cr -27%
Growth
Revenue CAGR 3Y	13.17%	14.94%	◆ 22.43%	17.85%	18.41% -28%
Revenue CAGR 5Y	17.76%	19.03%	◆ 27.30%	—	23.16% -23%
Net Income CAGR 3Y	18.91%	◆ 33.35%	9.34%	19.33%	20.67% -9%
Revenue YoY (latest Q)	17.46%	20.56%	20.31%	◆ 26.50%	22.46% -22%
Net Income YoY (latest Q)	2.26%	◆ 38.41%	-15.64%	-1.09%	7.23% -69%
Profitability
EBITDA Margin	22.84%	14.94%	◆ 26.79%	20.84%	20.86% +10%
Net Income Margin	11.66%	7.94%	◆ 17.23%	12.56%	12.58% -7%
Return on Common Equity	11.08%	◆ 21.95%	14.33%	15.15%	17.14% -35%
Return on Capital Employed	12.62%	◆ 18.20%	12.63%	14.78%	15.20% -17%
Return on Assets	7.18%	9.35%	8.89%	◆ 10.38%	9.54% -25%
Credit & Quality
Total Debt/Equity	◆ 0.28×	0.57×	0.32×	0.30×	0.40× -29%
Interest Coverage	5.20×	6.44×	7.64×	◆ 8.80×	7.63× -32%
Scale — latest FY
Revenue / Total Income	₹9,128 Cr	₹25,229 Cr	₹8,373 Cr	₹4,410 Cr	₹12,671 Cr -28%
Net Income	₹1,064 Cr	₹2,003 Cr	₹1,442 Cr	₹554 Cr	₹1,333 Cr -20%
Total Assets	₹15,966 Cr	₹22,197 Cr	₹17,231 Cr	₹5,905 Cr	₹15,111 Cr +6%
EPS	₹13.8	₹135.04	₹14.83	₹20.71	₹56.86 -76%
Book Value per Share	₹131.07	₹659.26	₹110.43	₹147.44	₹305.71 -57%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.